CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Ustekinumab

Last Updated: October 30, 2013
Result type: Reports
Project Number: SR0359-000
Product Line: Reimbursement Review

Generic Name: Ustekinumab

Brand Name: Stelara

Manufacturer: Janssen Inc.

Indications: Arthritis, Psoriatic

Submission Type: Pre-NOC

Project Status: Complete

Date Recommendation Issued: October 20, 2014

Recommendation Type: Do not list at the submitted price